enalapril and Sepsis

enalapril has been researched along with Sepsis* in 4 studies

Other Studies

4 other study(ies) available for enalapril and Sepsis

ArticleYear
Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models.
    Critical care medicine, 2009, Volume: 37, Issue:2

    Sepsis remains a major health threat in intensive care medicine. The renin-angiotensin system (ACE) affects inflammatory responses. In addition, angiotensin-converting enzyme inhibitors act to ameliorate lung injury. To investigate whether the widely used ACE inhibitor enalapril, used to treat hypertension, could inhibit secretion of cytokines and high-mobility group box 1 (HMGB1) protein, thus reducing lung damage in a rat model of lipopolysaccharide (LPS)-induced sepsis.. Randomized, prospective animal study.. University medical center research laboratory.. Male Wistar rats.. LPS was administered intravenously to rats, with or without intraperitoneal pretreatment with enalapril. In addition, mouse macrophage RAW264.7 cells were stimulated with LPS, with and without simultaneous enalapril treatment.. Histologic examination showed marked reduction of interstitial congestion, edema, inflammation, and hemorrhage in lung tissue harvested 12 hours after treatment with both agents compared with LPS administration alone. Plasma concentration of angiotensin II was strongly induced by LPS; this induction was inhibited by the enalapril pretreatment. Likewise, LPS-induced secretion of proinflammatory cytokines and HMGB1 protein was inhibited by enalapril. The presence of HMGB1 protein in the lung was examined directly by immunohistochemistry; the number of stained cells was significantly lower in LPS-treated animals that also received enalapril. In the in vitro studies, enalapril administration inhibited the phosphorylation of IkappaB.. The ACE inhibitor enalapril blocked the LPS-induced inflammatory response and protected against the acute lung injury normally associated with endotoxemia in this rat sepsis model. Given these results, enalapril is a strong candidate as a therapeutic agent for sepsis.

    Topics: Acute Lung Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cell Line; Cytokines; Enalapril; HMGB1 Protein; Lipopolysaccharides; Male; Mice; Random Allocation; Rats; Rats, Wistar; Sepsis

2009
Effects of the angiotensin converting enzyme inhibitor enalapril on bacterial translocation after thermal injury and bacterial challenge.
    Shock (Augusta, Ga.), 1996, Volume: 6, Issue:2

    Burn injury and sepsis produce acute gastrointestinal derangements that may predispose patients to bacterial translocation. We studied the effects of enalapril, an angiotensin converting enzyme inhibitor (ACEI), on gastrointestinal anatomic alterations, bacterial translocation, and related mortality during gut-derived sepsis in burned mice that had received a prior bacterial challenge. BALB/c mice (n = 111) were treated with enalapril 10 or 1 mg/kg body weight or sterile saline as control twice daily for 3 days. They were then gavaged with 10(a)111 in radiolabeled or unlabeled Escherichia coli and given a 20% total body surface area (TBSA) burn injury. Animals gavaged with unlabeled bacteria were observed for survival (n = 60). Survival was significantly higher in the group receiving enalapril 10 mg/Kg compared with control (75% vs. 10%). Mice treated with enalapril maintained small intestine weight, measured 4 h postburn, and ileal mucosal height was preserved, whereas burned untreated animals lost intestinal weight and mucosal height. Bacterial translocation was decreased in mice treated with enalapril, but killing was unaffected. This study suggests that treatment with enalapril positively affects the outcome in gut-derived sepsis by ameliorating gastrointestinal structural and functional damage and decreasing bacterial translocation.

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Burns; Drug Evaluation, Preclinical; Enalapril; Escherichia coli; Female; Intestines; Mice; Mice, Inbred BALB C; Sepsis; Splanchnic Circulation

1996
Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy.
    The American journal of medicine, 1987, Volume: 82, Issue:3

    Topics: Agranulocytosis; Angioedema; Captopril; Enalapril; Humans; Sepsis

1987
[Treatment with enalapril causing leukopenia with septicemia and affected liver].
    Lakartidningen, 1987, Apr-08, Volume: 84, Issue:15

    Topics: Aged; Enalapril; Humans; Leukopenia; Liver; Male; Sepsis

1987